Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 4Breast 3Thoracic 2Dermatologic 2

Conditions

Melanoma 346Carcinoma, Non-Small-Cell Lung 81Skin Neoplasms 71Carcinoma, Renal Cell 51Lung Neoplasms 49Neoplasm Metastasis 47Breast Neoplasms 45Colorectal Neoplasms 44Neoplasms 42Carcinoma, Basal Cell 42Uveal Melanoma 38Squamous Cell Carcinoma of Head and Neck 37Carcinoma, Merkel Cell 36Ovarian Neoplasms 35Sarcoma 31Lymphoma, T-Cell, Cutaneous 31Pancreatic Neoplasms 26Prostatic Neoplasms 24Carcinoma, Hepatocellular 23Stomach Neoplasms 21Head and Neck Neoplasms 21Uterine Cervical Neoplasms 20Urinary Bladder Neoplasms 20Thyroid Neoplasms 20Esophageal Neoplasms 19Brain Neoplasms 18Carcinoma, Squamous Cell 17Mycosis Fungoides 16Carcinoma, Transitional Cell 16Triple Negative Breast Neoplasms 15

Interventions

fludarabine phosphate 1fludarabine 1aldesleukin 1Spinal Puncture 1Specimen Handling 1Nivolumab 1Mesna 1Magnetic Resonance Spectroscopy 1Interleukin-2 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Meningeal Neoplasms × Dermatologic × 90 days × Clear all
NCT03025256 2026-05-05

Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease

M.D. Anderson Cancer Center

Phase 1 Recruiting
75 enrolled
DermatologicThoracic

Uveal Melanoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Melanoma, Meningeal Neoplasms, Nevus

NCT00338377 2026-03-20

Lymphodepletion Plus Adoptive Cell Transfer With or Without Dendritic Cell Immunization in Patients With Metastatic Melanoma

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
1,230 enrolled
Dermatologic

Melanoma, Meningeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡